Sign inGet started

English Emily

Insider CIK 2019791 · RNAC SVP, Head of Manufacturing

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RNAC Cartesian Therapeutics, In A Award deriv2026-01-022026-01-0671,000— $071,000SEC↗
RNAC Cartesian Therapeutics, In A Award2026-01-022026-01-0624,000— $094,226SEC↗
RNAC Cartesian Therapeutics, In M Exercise deriv2025-12-302026-01-027,500— $019,369SEC↗
RNAC Cartesian Therapeutics, In M Exercise2025-12-302026-01-027,500$3.30 $24.8K70,226SEC↗
RNAC Cartesian Therapeutics, In M Exercise deriv2025-11-282025-12-027,500— $026,869SEC↗
RNAC Cartesian Therapeutics, In M Exercise2025-11-282025-12-027,500$3.30 $24.8K62,726SEC↗
RNAC Cartesian Therapeutics, In M Exercise deriv2025-05-122025-05-147,500— $034,369SEC↗
RNAC Cartesian Therapeutics, In M Exercise2025-05-122025-05-147,500$3.30 $24.8K55,226SEC↗
RNAC Cartesian Therapeutics, In M Exercise deriv2025-04-152025-04-167,500— $041,869SEC↗
RNAC Cartesian Therapeutics, In M Exercise2025-04-152025-04-167,500$3.30 $24.8K47,726SEC↗
RNAC Cartesian Therapeutics, In S Sale2025-01-062025-01-07906$16.83 $15.2K40,226SEC↗
RNAC Cartesian Therapeutics, In S Sale2025-01-032025-01-07891$16.72 $14.9K41,132SEC↗
RNAC Cartesian Therapeutics, In A Award deriv2025-01-022025-01-0647,400— $047,400SEC↗
RNAC Cartesian Therapeutics, In A Award2025-01-022025-01-0616,100— $042,023SEC↗
RNAC Cartesian Therapeutics, In M Exercise deriv2024-12-262024-12-307,650— $049,369SEC↗
RNAC Cartesian Therapeutics, In M Exercise2024-12-262024-12-307,650$3.30 $25.2K25,923SEC↗